It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Ethics Board Approval Granted for Lexaria Receives Ethics Board Approval for 12-Week Phase 1b DehydraTECH GLP-1 Study in ...

DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global i ...

The Company is also announcing that clinical test article manufacturing for all planned Study arms has already been completed. This includes production for the four planned DehydraTECH formulation ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Ozempic has been a hot topic in Hollywood with stars either admitting to using the diabetes drug for weight loss or staunchly ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Little surprise then that, this May, the health analytics company Airfinity calculated that a record 322 weight-loss medications were currently ... while Wegovy is prescribed by the NHS for weight ...

Rybelsus: Novo Nordisk’s name ... typically in a daily dosage two separate brand name medications: Mounjaro and Zepbound. FDA ...

Oral semaglutide is already sold as Rybelsus in a 14 mg formulation ... weight in diabetics. It was a dose-ranging study, and the range of weight loss seen with Lilly’s drug was 9.4% to 14.7 ...